ArticleNature medicine1998
Why do we not have an HIV vaccine and how can we make one? .
Article in Nature medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- Applications of molecular networks in biomedicine.Biology methods & protocols · 2019Review
- Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.Journal of immunology (Baltimore, Md. : 1950) · 2009Article
- Immunogenicity of the outer domain of a HIV-1 clade C gp120.Retrovirology · 2007Article
- Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.Journal of virology · 2006Article
- Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.Journal of virology · 2005Article
- Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni.Medical microbiology and immunology · 2005Article
- Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism.EMBO reports · 2004Article
- Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.Journal of virology · 2003Article
- Article
- The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.Proceedings of the National Academy of Sciences of the United States of America · 2003Article
- Protein grafting of an HIV-1-inhibiting epitope.Proceedings of the National Academy of Sciences of the United States of America · 2003Article
- Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.Journal of virology · 2003Article
- Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.Journal of virology · 2003Article
- Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site.Journal of virology · 2003Article
- CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.Journal of virology · 2003Article
- Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein.Journal of virology · 2002Article
- [Immunization: leaps into the future. The vaccinology at the beginning of the 21th century (II)].Atencion primaria · 2002Review
- Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.Clinical and diagnostic laboratory immunology · 2002Review
- Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.Journal of virology · 2002Article
- Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.Journal of virology · 2002Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
9585194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.